Dimension Therapeutics News Timeline Breakdown

DMTX -- USA Stock  

null 5.95  0.00  0.00%

This is yet another view into Dimension Therapeutics filtered headlines to help investors concentrate on Dimension Therapeutics noise-free news that matters. Some academic researchers believe in strong correlation between financial news and their impacts to the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Dimension Therapeutics headlines in addition to utilizing other more conventional financial analysis modules. Additionally see Investing Opportunities.
news
September 4, 2018
Payment of 994 shares by Pat Cotroneo of FibroGen subject to Rule 16b-3 at thewellesleysnews.com 
View Story
Macroaxis News
September 12, 2018
Sale by Pat Cotroneo of 1011 shares of FibroGen at MacroaxisInsider 
View Story
news
August 31, 2018
Exercise or conversion by K Yu of 1800 shares of FibroGen subject to Rule 16b-3 at cardinalweekly.com 
View Story
news
September 18, 2018
Earnings Estimates Revision Screen Hutchison China MediTech Limited at thewellesleysnews.com 
View Story
news
September 5, 2018
Analysts Are Bullish on These Healthcare Stocks Agios Pharma , Tactile Systems Technology at www.analystratings.com 
View Story
news
September 12, 2018
New 52-Week High Stock of Quidel Corporation at finherald.com 
View Story
businessinsider News
September 19, 2018
Acquisition by Robert Bujarski of 1025 shares of Quidel subject to Rule 16b-3 at markets.businessinsider.com 
View Story
news
September 7, 2018
Exercise or conversion by Ratan Borkar of 12431 shares of Quidel subject to Rule 16b-3 at finbulletin.com 
View Story
Macroaxis News
August 31, 2018
Sale by Isaac Ciechanover of 2800 shares of Atara Biotherapeutics at MacroaxisInsider 
View Story
Macroaxis News
September 14, 2018
Sale by Philip Worboys of 6393 shares of Theravance Biopharma at MacroaxisInsider 
View Story
news
September 18, 2018
Global Opioid Induced Constipation Drugs Market Report 2018-2025 at marketresearchday.com 
View Story
news
September 7, 2018
Securities Analyst Recommendations Theravance Biopharma, Inc. , Verso Corporation at thewellesleysnews.com 
View Story
news
September 12, 2018
Stock in the News Investors Keen on Assembly Biosciences, Inc. as it Makes Headlines With Moves at www.thecoinguild.com 
View Story
Macroaxis News
September 21, 2018
Sale by Gordon G Irwin of 100 shares of Heska at MacroaxisInsider 
View Story
news
September 18, 2018
Heska Corp COO Jason A. Napolitano Sells 2500 Shares of Stock at www.fairfieldcurrent.com 
View Story
news
September 7, 2018
Are You Looking For Active Stock Heska Corporation at nysedaily.com 
View Story
news
September 6, 2018
Stocks in the News Investors Taking a Second Look at NuCana PLC Sponsored ADR After Recent Market ... at www.thecoinguild.com 
View Story
news
September 19, 2018
Small-Cap Snapshot Ballard Power Systems shares gain traction with new liquid-cooled fuel cell stack at www.proactiveinvestors.com 
View Story
news
September 24, 2018
Choosing Between Hot Stocks Fate Therapeutics, Inc. , Agenus Inc. at stocknewsgazette.com 
View Story
news
August 31, 2018
Investment Research Analysts Opinion Fate Therapeutics, Inc. , Intercept Pharmaceuticals, Inc. at thewellesleysnews.com 
View Story

Did you try this?

Run Portfolio Manager Now

   

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
All  Next Launch Portfolio Manager

Dimension Therapeutics Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Dimension Therapeutics and FibroGen. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Additionally see Investing Opportunities. Please also try Instant Ratings module to determine any equity ratings based on digital recommendations. macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Search macroaxis.com